Kindred Biosciences Announces Plans for Promotion of Dr. Zhan and Retirement of Dr. Sundlof

SAN FRANCISCO, Sept. 11, 2017 -- (Healthcare Sales & Marketing Network) -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that Dr. Stephen Sundlof will retire in Janu... Biopharmaceuticals, Personnel Kindred Biosciences
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news